Acquired hemophilia A (and other acquired coagulation factor inhibitors) (2025) Paula James

Description

This topic review discusses the evaluation and management of acquired hemophilia A (acquired factor VIII inhibitor) and other acquired clotting factor inhibitors. These autoantibodies inhibit the activity or increase the clearance of a clotting factor, often leading to unexplained bleeding and prolonged clotting times.